{
  "paper_id": "PMC5984916",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984916/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Patient selection from the database. BI basal insulin, HbA1c glycated hemoglobin, OAD oral antidiabetic, T2D type 2 diabetes",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/11a6bea47a28/13300_2018_413_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/11a6bea47a28/13300_2018_413_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/11a6bea47a28/13300_2018_413_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/11a6bea47a28/13300_2018_413_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/11a6bea47a28/13300_2018_413_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC5984916/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/11a6bea47a28/13300_2018_413_Fig1_HTML.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2.",
      "caption": "Percentage of patients reaching their first HbA1c < 7% post-BI initiation. The numerator is defined as the number of patients who reached glycemic control (HbA1c < 7%) for the first time during each corresponding quarter; the denominator is defined as the number of patients who did not reach glycemic control prior to that quarter AND were still on BI treatment AND had at least one valid electronic medical records entry in that quarter. BI basal insulin, HbA1c glycated hemoglobin",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e356699658cd/13300_2018_413_Fig2_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e356699658cd/13300_2018_413_Fig2_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e356699658cd/13300_2018_413_Fig2_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e356699658cd/13300_2018_413_Fig2_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e356699658cd/13300_2018_413_Fig2_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC5984916/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e356699658cd/13300_2018_413_Fig2_HTML.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Fig. 3.",
      "caption": "Kaplan–Meier curves for time to reach glycemic control (HbA1c < 7%) for the overall study cohort and the four subcohorts. BI basal insulin, HbA1c glycated hemoglobin, OAD oral antidiabetic",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e6d60d9cee5c/13300_2018_413_Fig3_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e6d60d9cee5c/13300_2018_413_Fig3_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e6d60d9cee5c/13300_2018_413_Fig3_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e6d60d9cee5c/13300_2018_413_Fig3_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e6d60d9cee5c/13300_2018_413_Fig3_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC5984916/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/406f/5984916/e6d60d9cee5c/13300_2018_413_Fig3_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "A flow diagram showing inclusion and exclusion of the patients in the study cohort is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Results\nBaseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Few patients had multiple HbA1c records across two or more periods post-BI initiation\nBI basal insulin, HbA1c glycated hemoglobin, SD standard deviation\nPatients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "After 12 months post-BI initiation, it diminished further to ≤ 6.1% during any quarter in the second year.Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Baseline Demographics and Clinical Characteristics\nOur study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Our study cohort included a total of 6597 patients selected from the clinical EMR database (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Patients Achieving Glycemic Control (HbA1c < 7%)\nThe percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentage of patients who registered an HbA1c < 7% for the first time, out of the number of those patients who were still in the cohort, was calculated for each quarter after the index date (Fig. 2, Table 4).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The percentages of patients reaching HbA1c < 7% for the first time in that quarter are shown in Fig. 2 and Table 4, column E.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Time to Reach First Glycemic Control Analyses\nThe Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The Kaplan–Meier curves of the time to reach HbA1c < 7% showed similar trends for the overall cohort (Fig. 3, dotted line) as well as across all four subcohorts of concomitant OAD usage (Fig. 3, solid lines).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The cumulative probability of reaching glycemic control over time (Fig. 3) revealed that about 38% of patients reached glycemic control in the first 12 months but only about 8% more did so in the second year.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 3,
    "claims_count": 65,
    "images_downloaded": 3,
    "tables_filtered": 166
  }
}